ID   KCNT1_RAT               Reviewed;        1237 AA.
AC   Q9Z258; Q5D6C6;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   02-OCT-2024, entry version 144.
DE   RecName: Full=Potassium channel subfamily T member 1;
DE   AltName: Full=Sequence like a calcium-activated potassium channel subunit;
GN   Name=Kcnt1; Synonyms=Slack;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10196543; DOI=10.1038/2176;
RA   Joiner W.J., Tang M.D., Wang L.-Y., Dworetzky S.I., Boissard C.G., Gan L.,
RA   Gribkoff V.K., Kaczmarek L.K.;
RT   "Formation of intermediate-conductance calcium-activated potassium channels
RT   by interaction of Slack and Slo subunits.";
RL   Nat. Neurosci. 1:462-469(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   STRAIN=Sprague-Dawley;
RA   Bhattacharjee A., von Hehn C.A., Kaczmarek L.K.;
RT   "An alternative isoform of the sodium-activated potassium channel Slack
RT   exhibits fast gating kinetics.";
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12442315; DOI=10.1002/cne.10439;
RA   Bhattacharjee A., Gan L., Kaczmarek L.K.;
RT   "Localization of the Slack potassium channel in the rat central nervous
RT   system.";
RL   J. Comp. Neurol. 454:241-254(2002).
RN   [4]
RP   FUNCTION.
RX   PubMed=12628167; DOI=10.1016/s0896-6273(03)00096-5;
RA   Yuan A., Santi C.M., Wei A., Wang Z.W., Pollak K., Nonet M., Kaczmarek L.,
RA   Crowder C.M., Salkoff L.;
RT   "The sodium-activated potassium channel is encoded by a member of the Slo
RT   gene family.";
RL   Neuron 37:765-773(2003).
RN   [5]
RP   SUBCELLULAR LOCATION, TOPOLOGY, AND INTERACTION WITH CRBN.
RX   PubMed=16045448; DOI=10.1111/j.1471-4159.2005.03344.x;
RA   Jo S., Lee K.-H., Song S., Jung Y.-K., Park C.-S.;
RT   "Identification and functional characterization of cereblon as a binding
RT   protein for large-conductance calcium-activated potassium channel in rat
RT   brain.";
RL   J. Neurochem. 94:1212-1224(2005).
RN   [6]
RP   FUNCTION, PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RX   PubMed=16687497; DOI=10.1523/jneurosci.3372-05.2006;
RA   Santi C.M., Ferreira G., Yang B., Gazula V.R., Butler A., Wei A.,
RA   Kaczmarek L.K., Salkoff L.;
RT   "Opposite regulation of Slick and Slack K+ channels by neuromodulators.";
RL   J. Neurosci. 26:5059-5068(2006).
RN   [7]
RP   INTERACTION WITH FMR1.
RX   PubMed=20512134; DOI=10.1038/nn.2563;
RA   Brown M.R., Kronengold J., Gazula V.R., Chen Y., Strumbos J.G.,
RA   Sigworth F.J., Navaratnam D., Kaczmarek L.K.;
RT   "Fragile X mental retardation protein controls gating of the sodium-
RT   activated potassium channel Slack.";
RL   Nat. Neurosci. 13:819-821(2010).
RN   [8]
RP   MUTAGENESIS OF ARG-409 AND ALA-913.
RX   PubMed=23086397; DOI=10.1038/ng.2441;
RA   Barcia G., Fleming M.R., Deligniere A., Gazula V.R., Brown M.R.,
RA   Langouet M., Chen H., Kronengold J., Abhyankar A., Cilio R., Nitschke P.,
RA   Kaminska A., Boddaert N., Casanova J.L., Desguerre I., Munnich A.,
RA   Dulac O., Kaczmarek L.K., Colleaux L., Nabbout R.;
RT   "De novo gain-of-function KCNT1 channel mutations cause malignant migrating
RT   partial seizures of infancy.";
RL   Nat. Genet. 44:1255-1259(2012).
RN   [9]
RP   FUNCTION, AND MUTAGENESIS OF ALA-945.
RX   PubMed=24463883; DOI=10.1093/hmg/ddu030;
RG   WGS500 Consortium;
RA   Martin H.C., Kim G.E., Pagnamenta A.T., Murakami Y., Carvill G.L.,
RA   Meyer E., Copley R.R., Rimmer A., Barcia G., Fleming M.R., Kronengold J.,
RA   Brown M.R., Hudspith K.A., Broxholme J., Kanapin A., Cazier J.B.,
RA   Kinoshita T., Nabbout R., Bentley D., McVean G., Heavin S., Zaiwalla Z.,
RA   McShane T., Mefford H.C., Shears D., Stewart H., Kurian M.A.,
RA   Scheffer I.E., Blair E., Donnelly P., Kaczmarek L.K., Taylor J.C.;
RT   "Clinical whole-genome sequencing in severe early-onset epilepsy reveals
RT   new genes and improves molecular diagnosis.";
RL   Hum. Mol. Genet. 23:3200-3211(2014).
CC   -!- FUNCTION: Outwardly rectifying potassium channel subunit that may
CC       coassemble with other Slo-type channel subunits. Activated by high
CC       intracellular sodium or chloride levels. Activated upon stimulation of
CC       G-protein coupled receptors, such as CHRM1 and GRIA1. May be regulated
CC       by calcium in the absence of sodium ions (in vitro).
CC       {ECO:0000269|PubMed:10196543, ECO:0000269|PubMed:12628167,
CC       ECO:0000269|PubMed:16687497, ECO:0000269|PubMed:24463883}.
CC   -!- SUBUNIT: Interacts (via C-terminus) with FMR1; this interaction alters
CC       gating properties of KCNT1 (By similarity). Interacts with CRBN via its
CC       cytoplasmic C-terminus (PubMed:16045448).
CC       {ECO:0000250|UniProtKB:Q5JUK3, ECO:0000269|PubMed:16045448}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12442315,
CC       ECO:0000269|PubMed:16045448}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12442315, ECO:0000269|PubMed:16045448}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Z258-1; Sequence=Displayed;
CC       Name=2; Synonyms=SLACK-A;
CC         IsoId=Q9Z258-2; Sequence=VSP_015472;
CC   -!- TISSUE SPECIFICITY: Detected in brain and brainstem, in vestibular and
CC       oculomotor nuclei, the medial nucleus of the trapezoid in the auditory
CC       system, in olfactory bulb, red nucleus, and deep cerebellar nuclei.
CC       Detected in thalamus, substantia nigra, and amygdala (at protein
CC       level). Highly expressed in the brain and kidney.
CC       {ECO:0000269|PubMed:10196543, ECO:0000269|PubMed:12442315,
CC       ECO:0000269|PubMed:16687497}.
CC   -!- PTM: Phosphorylated by protein kinase C. Phosphorylation of the C-
CC       terminal domain increases channel activity.
CC       {ECO:0000269|PubMed:16687497}.
CC   -!- SIMILARITY: Belongs to the potassium channel family. Calcium-activated
CC       (TC 1.A.1.3) subfamily. KCa4.1/KCNT1 sub-subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF089730; AAC83350.1; -; mRNA.
DR   EMBL; AY884213; AAX16016.1; -; mRNA.
DR   PIR; T46609; T46609.
DR   RefSeq; NP_068625.1; NM_021853.1.
DR   AlphaFoldDB; Q9Z258; -.
DR   SMR; Q9Z258; -.
DR   STRING; 10116.ENSRNOP00000023542; -.
DR   BindingDB; Q9Z258; -.
DR   ChEMBL; CHEMBL4739708; -.
DR   DrugCentral; Q9Z258; -.
DR   GuidetoPHARMACOLOGY; 385; -.
DR   TCDB; 1.A.1.3.4; the voltage-gated ion channel (vic) superfamily.
DR   GlyCosmos; Q9Z258; 2 sites, No reported glycans.
DR   GlyGen; Q9Z258; 2 sites.
DR   iPTMnet; Q9Z258; -.
DR   PhosphoSitePlus; Q9Z258; -.
DR   PaxDb; 10116-ENSRNOP00000023542; -.
DR   ABCD; Q9Z258; 1 sequenced antibody.
DR   GeneID; 60444; -.
DR   KEGG; rno:60444; -.
DR   UCSC; RGD:621106; rat. [Q9Z258-1]
DR   AGR; RGD:621106; -.
DR   CTD; 57582; -.
DR   RGD; 621106; Kcnt1.
DR   eggNOG; KOG3193; Eukaryota.
DR   InParanoid; Q9Z258; -.
DR   OrthoDB; 2907493at2759; -.
DR   PhylomeDB; Q9Z258; -.
DR   PRO; PR:Q9Z258; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098839; C:postsynaptic density membrane; ISO:RGD.
DR   GO; GO:0070089; F:chloride-activated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0005228; F:intracellular sodium-activated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0015271; F:outward rectifier potassium channel activity; IBA:GO_Central.
DR   GO; GO:0005267; F:potassium channel activity; IDA:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; IDA:RGD.
DR   GO; GO:0060078; P:regulation of postsynaptic membrane potential; ISO:RGD.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 2.
DR   InterPro; IPR003929; K_chnl_BK_asu.
DR   InterPro; IPR013099; K_chnl_dom.
DR   InterPro; IPR047871; K_chnl_Slo-like.
DR   PANTHER; PTHR10027; CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA CHAIN; 1.
DR   PANTHER; PTHR10027:SF14; POTASSIUM CHANNEL SUBFAMILY T MEMBER 1; 1.
DR   Pfam; PF03493; BK_channel_a; 1.
DR   Pfam; PF07885; Ion_trans_2; 1.
DR   Pfam; PF22614; Slo-like_RCK; 2.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 1.
DR   PROSITE; PS51201; RCK_N; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Glycoprotein; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..1237
FT                   /note="Potassium channel subfamily T member 1"
FT                   /id="PRO_0000054092"
FT   TOPO_DOM        1..97
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        98..118
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        119..155
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        156..176
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        177..187
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        188..208
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        209..213
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        214..226
FT                   /note="Helical; Name=Segment S4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        227..251
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        252..272
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        273..281
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        282..302
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        303..304
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        305..325
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        326..1237
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          352..488
FT                   /note="RCK N-terminal 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00543"
FT   DOMAIN          779..919
FT                   /note="RCK N-terminal 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00543"
FT   REGION          1..45
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          658..687
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1051..1079
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1210..1237
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        133
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        137
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         1..66
FT                   /note="MARAKLPRSPSEGKAGPGDTPAGSAAPEEPHGLSPLLPTRGGGSVGSDVGQR
FT                   LHVEDFSLDSSLSQ -> MNDLDTEVLPLPPRYRFRDLLLGDQTFPNDDR (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_015472"
FT   MUTAGEN         409
FT                   /note="R->Q: Generates currents that resembles wild-type in
FT                   terms of voltage dependence and kinetic behavior but has
FT                   2- to 3-fold higher amplitude compared to wild-type. The
FT                   mutation shows to cause constitutive activation of the
FT                   channel, mimicking the effects of phosphorylation of the C-
FT                   terminal domain by PRKCA activation."
FT                   /evidence="ECO:0000269|PubMed:23086397"
FT   MUTAGEN         913
FT                   /note="A->T: Generates currents that resembles wild-type in
FT                   terms of voltage dependence and kinetic behavior but has
FT                   2- to 3-fold higher amplitude compared to wild-type. The
FT                   mutation shows to cause constitutive activation of the
FT                   channel, mimicking the effects of phosphorylation of the C-
FT                   terminal domain by PRKCA activation."
FT                   /evidence="ECO:0000269|PubMed:23086397"
FT   MUTAGEN         945
FT                   /note="A->T: Increases channel activity upon positive
FT                   potentials. The mutation corresponds to probable disease-
FT                   associated variant in humans."
FT                   /evidence="ECO:0000269|PubMed:24463883"
SQ   SEQUENCE   1237 AA;  139615 MW;  E11B4A7A77EB612B CRC64;
     MARAKLPRSP SEGKAGPGDT PAGSAAPEEP HGLSPLLPTR GGGSVGSDVG QRLHVEDFSL
     DSSLSQVQVE FYVNENTFKE RLKLFFIKNQ RSSLRIRLFN FSLKLLTCLL YIVRVLLDNP
     DQGIGCWGCT KYNYTFNGSS SEFHWAPILW VERKMALWVI QVIVATISFL ETMLLIYLSY
     KGNIWEQIFH VSFVLEMINT LPFIITVFWP PLRNLFIPVF LNCWLAKHAL ENMINDFHRA
     ILRTQSAMFN QVLILFCTLL CLVFTGTCGI QHLERAGGNL NLLTSFYFCI VTFSTVGFGD
     VTPKIWPSQL LVVILICVTL VVLPLQFEEL VYLWMERQKS GGNYSRHRAR TEKHVVLCVS
     SLKIDLLMDF LNEFYAHPRL QDYYVVILCP SEMDVQVRRV LQIPLWSQRV IYLQGSALKD
     QDLMRAKMDN GEACFILSSR NEVDRTAADH QTILRAWAVK DFAPNCPLYV QILKPENKFH
     VKFADHVVCE EECKYAMLAL NCICPATSTL ITLLVHTSRG QEGQESPEQW QRMYGRCSGN
     EVYHIRMGDS KFFREYEGKS FTYAAFHAHK KYGVCLIGLK REENKSILLN PGPRHILAAS
     DTCFYINITK EENSAFIFKQ EEKQNRRGLA GQALYEGPSR LPVHSIIASM VAMDLQNTDC
     RPSQGGSGGG GGKLTLPTEN GSGSRRPSIA PVLELADSSA LLPCDLLSDQ SEDEVTPSDD
     EGLSVVEYVK GYPPNSPYIG SSPTLCHLLP VKAPFCCLRL DKGCKHNSYE DAKAYGFKNK
     LIIVSAETAG NGLYNFIVPL RAYYRSRREL NPIVLLLDNK PDHHFLEAIC CFPMVYYMEG
     SVDNLDSLLQ CGIIYADNLV VVDKESTMSA EEDYMADAKT IVNVQTMFRL FPSLSITTEL
     THPSNMRFMQ FRAKDSYSLA LSKLEKQERE NGSNLAFMFR LPFAAGRVFS ISMLDTLLYQ
     SFVKDYMITI TRLLLGLDTT PGSGYLCAMK VTEDDLWIRT YGRLFQKLCS SSAEIPIGIY
     RTECHVFSSE PHDLRAQSQI SVNMEDCEDT REAKGPWGTR AASGGGSTHG RHGGSADPVE
     HPLLRRKSLQ WARKLSRKSS KQAGKAPMTT DWITQQRLSL YRRSERQELS ELVKNRMKHL
     GLPTTGYEDV ANLTASDVMN RVNLGYLQDE MNDHHQNTLS YVLINPPPDT RLEPNDIVYL
     IRSDPLAHVT SSSQSRKSSC SNKLSSCNPE TRDETQL
//
